Cancer Clinical Trial
— HomePalOfficial title:
A Non-Inferiority Comparative Effectiveness Trial of Home-Based Palliative Care in Older Adults
Verified date | February 2020 |
Source | Kaiser Permanente |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: To effectively alleviate suffering and improve quality of life for patients with
serious illness and their caregivers, palliative care (PC) services must be offered across
multiple settings. Research is needed to determine how best to optimize home-based palliative
care (HBPC) services to meet the needs of individuals with high symptom burden and functional
limitations.
Aim: The investigators will compare a standard HBPC model that includes routine home visits
by a nurse and provider with a more efficient tech-supported HBPC model that promotes timely
inter-professional team coordination via synchronous video consultation with the provider
while the nurse is in the patient's home. The investigators hypothesize that tech-supported
HBPC will be as effective as standard HBPC.
Design: Cluster randomized trial. Registered nurses (n~130) will be randomly assigned to the
tech-supported or standard HBPC model so that half of the patient-caregiver dyads will
receive one of the two models.
Setting/Participants: Kaiser Permanente (15 Southern California and Oregon sites). Patients
(n=10,000) with any serious illness and a prognosis of 1-2 years and their caregivers
(n=4,800)
Methods: Patients and caregivers will receive standard PC services: comprehensive needs
assessment and care planning, pain and symptom management, education/skills training,
medication management, emotional/spiritual support; care coordination, referral to other
services, and 24/7 phone assistance.
Results: Primary patient outcomes: symptom improvement at 1 month and days spent at home in
the last six months of life; caregiver outcome: perception of preparedness for caregiving.
Conclusion: Should the more efficient tech-supported HBPC model achieves comparable
improvements in outcomes that matter most to patients and caregivers, this would have a
lasting impact on PC practice and policy.
Status | Terminated |
Enrollment | 3999 |
Est. completion date | January 24, 2020 |
Est. primary completion date | January 24, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Patient Inclusion Criteria: - Serious illness with 12-24 month life expectancy - Homebound - Need for skilled nursing care (only at KP Southern California) - English or Spanish speakers Patient Exclusion Criteria: - Currently receiving HBPC Caregiver Inclusion Criteria: - Non-professional family, friend or other caregiver - English or Spanish speakers |
Country | Name | City | State |
---|---|---|---|
United States | Kaiser Permanente Southern California | Pasadena | California |
United States | Kaiser Permanente Northwest | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Kaiser Permanente | Patient-Centered Outcomes Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Symptom severity (total score) using the Edmonton Symptom Assessment Scale (ESAS) | The ESAS is a 10-item survey measuring symptom severity. Scores range from 0-100 with higher scores indicating worse symptoms. | Change from baseline to 1 month | |
Primary | Days at home in the last 180 days of life among patients surviving at least 180 days after enrolling in HBPC | Baseline to 12 months | ||
Primary | Caregiver preparedness for caregiving using the Preparedness for Caregiving Scale | The Preparedness for Caregiving Scale is a 9-item survey measuring caregivers' perception of their preparedness for caregiving. Scores range from 0-36 with higher scores indicating higher perception of preparedness | Change from baseline to 1 month | |
Secondary | Days at home between study enrollment and death or study completion (365 days) | Variable, up to 12 months | ||
Secondary | Patient quality of life measured with the PROMIS-10 survey | The PROMIS-10 is a 10-item survey measuring general health related quality of life. Scores range from 0-100 with higher scores indicating better quality of life | Change from baseline to 1 and 6 months | |
Secondary | Patient general distress measured with the distress thermometer | Scores for this single item distress thermometer range from 0-10 with higher scores indicating greater distress | Change from baseline to 1 and 6 months | |
Secondary | Palliative performance scale will be measured using all data available from routine clinical practice as documented in the electronic medical record (EMR) | The Palliative Performance Scale measures overall functional status. A clinician completes this assessment using a scale of 0-100 with higher scores indicating better functional performance | Baseline and variable time periods due to reliance on available data from the EMR | |
Secondary | Patient satisfaction-care experience measured by a study-specific survey | This 8-item satisfaction-care experience survey was developed specifically to measure satisfaction and care experience with home-based palliative care. | 1 and 6 months | |
Secondary | Patient acute and post-acute care utilization | Frequency of hospitalizations, emergency department visits and skilled nursing facility stay | Baseline to 12 months | |
Secondary | Patient outpatient health care utilization | Frequency of primary and specialty care visits | Baseline to 12 months | |
Secondary | Patient enrollment in and days on hospice before death | Baseline to 12 months | ||
Secondary | Patient death | Baseline to 12 months | ||
Secondary | Caregiver quality of life measured with the PROMIS-10 | The PROMIS-10 is a 10-item survey measuring general health related quality of life. Scores range from 0-100 with higher scores indicating better quality of life | Change from baseline to 1 and 6 months | |
Secondary | Caregiver burden measured with the Zarit-12 Caregiver Burden Scale | The Zarit-12 is a 12-item survey measuring caregiver burden. Scores range from 0-48 with higher scores indicating greater caregiver burden | Change from baseline to 1 and 6 months | |
Secondary | Caregiver acute and post-acute care utilization | Frequency of hospitalizations, emergency department visits and skilled nursing facility stay for caregivers who are members of Kaiser Permanente | Baseline to 12 months | |
Secondary | Caregiver outpatient health care utilization | Frequency of primary and specialty care visits for caregivers who are members of Kaiser Permanente | Baseline to 12 months | |
Secondary | HBPC clinician perception of facilitators and barriers to implementation of HBPC services | Study specific survey (under development) | Yearly, up to four years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|